Skip to main content
TipRanks
Go Ultimate75% OFF

Guangzhou Baiyunshan Pharmaceutical Holdings Company (0874) Income Statement

0 Followers

Guangzhou Baiyunshan Pharmaceutical Holdings Company Income Statement

Last quarter (Q3 2026), Guangzhou Baiyunshan Pharmaceutical Holdings Company's total revenue was ¥19.98B, an increase of 1.10% from the same quarter last year. In Q3, Guangzhou Baiyunshan Pharmaceutical Holdings Company's net income was ¥395.57M. See Guangzhou Baiyunshan Pharmaceutical Holdings Company’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 77.66B¥ 74.99B¥ 75.52B¥ 70.79B¥ 69.01B
¥ 12.52B¥ 12.52B¥ 14.19B¥ 13.28B¥ 13.23B
¥ 8.89B¥ 8.92B¥ 9.07B¥ 8.73B¥ 8.85B
Depreciation and Amortization¥ 931.11M¥ 875.24M¥ 929.44M¥ 743.83M¥ 676.99M
¥ 3.95B¥ 4.90B¥ 6.49B¥ 6.22B¥ 5.82B
¥ 3.63B¥ 3.60B¥ 5.12B¥ 5.07B¥ 4.79B
¥ 61.13M¥ 11.19M¥ -10.40M¥ -31.16M¥ -62.97M
¥ 3.69B¥ 3.61B¥ 5.11B¥ 5.04B¥ 4.72B
¥ 2.98B¥ 2.84B¥ 4.06B¥ 3.97B¥ 3.72B
Per Share Metrics
Basic EPS¥ 1.83¥ 1.74¥ 2.49¥ 2.44¥ 2.29
Diluted EPS¥ 1.83¥ 1.74¥ 2.49¥ 2.44¥ 2.29
Weighted Average Shares Outstanding1.63B1.63B1.63B1.63B1.63B
Weighted Average Shares Outstanding (Diluted)1.63B1.63B1.63B1.63B1.63B

Currency in CNY

Guangzhou Baiyunshan Pharmaceutical Holdings Company Earnings and Revenue History

030B60B90B3 %6 %9 %12 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin